UPCOMING WEBINARS

 

AI in early Drug Discovery: From Promise to Practice

Wednesday 18th May, 3:30 GMT

 


 

 

 
 
Join Jeff Blaney (Genentech), Darren Green (GSK) Julian Levell (New Equilibrium Biosciences) and Matt Segall (Optibrium), for this panel on the state of AI in early drug discovery from hit to preclinical candidate. The panellists will share their experiences with and expectations of AI, including predictive modelling, synthesis prediction and generative chemistry. Hear about the successes of AI and an outlook on what AI needs to achieve to really transform drug discovery.
 
Host: Tim Hohm,  Director of Commercial Strategy and Business Development, Optibrium
 
Panel:
Matt Segall, CEO, Optibrium
Darren Green, Head of Cheminformatics & Data Science, GSK   
Jeff Blaney, Senior Director of Discovery Chemistry ,Genentech   
Julian Levell, Head of Discovery, New Equilibrium Biosciences 
 
 
 

Get involved at BioTechX

 

 

TO SPONSOR


Alistair Wilmot

alistair.wilmot@terrapinn.com

 


Danielle Thomas

danielle.thomas@terrapinn.com

 

TO SPEAK


Chris Shanks

chris.shanks@terrapinn.com

 


Joanna Magaji

joanna.magaji@terrapinn.com

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com